UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Gamma-secretase activating protein is a therapeutic target for Alzheimer's disease

Nature (London), 2010-09, Vol.467 (7311), p.95-98

2010

Volltextzugriff (PDF)

Acute Enhancement of Cardiac Function by Phosphodiesterase Type 1 Inhibition: Translational Study in the Dog and Rabbit

Circulation (New York, N.Y.), 2018-10, Vol.138 (18), p.1974-1987

2018

Volltextzugriff (PDF)

Functional profile of a novel modulator of serotonin, dopamine, and glutamate neurotransmission

Psychopharmacology, 2015-02, Vol.232 (3), p.605-621

2015

Volltextzugriff (PDF)

Discovery of a Tetracyclic Quinoxaline Derivative as a Potent and Orally Active Multifunctional Drug Candidate for the Treatment of Neuropsychiatric and Neurological Disorders

Journal of medicinal chemistry, 2014-03, Vol.57 (6), p.2670-2682

2014

Volltextzugriff (PDF)

Discovery of Potent and Selective Inhibitors of Phosphodiesterase 1 for the Treatment of Cognitive Impairment Associated with Neurodegenerative and Neuropsychiatric Diseases

Journal of medicinal chemistry, 2016-02, Vol.59 (3), p.1149-1164

2016

Volltextzugriff (PDF)

Inhibition of calcium-calmodulin-dependent phosphodiesterase (PDE1) suppresses inflammatory responses

Molecular and cellular neuroscience, 2020-01, Vol.102, p.103449-103449, Article 103449

2020

Volltextzugriff (PDF)

Preclinical profile of ITI-214, an inhibitor of phosphodiesterase 1, for enhancement of memory performance in rats

Psychopharmacology, 2016-09, Vol.233 (17), p.3113-3124

2016

Volltextzugriff (PDF)

Phosphodiesterase 1: A Unique Drug Target for Degenerative Diseases and Cognitive Dysfunction

Advances in neurobiology, 2017, Vol.17, p.349-384

2017

Volltextzugriff (PDF)

Muscarinic receptors acting at pre- and post-synaptic sites differentially regulate dopamine/DARPP-32 signaling in striatonigral and striatopallidal neurons

Neuropharmacology, 2012-12, Vol.63 (7), p.1248-1257

2012

Volltextzugriff (PDF)

In vivo observation of polypeptide flux through the bacterial chaperonin system

Cell, 1997-08, Vol.90 (3), p.491-500

1997

Volltextzugriff (PDF)

General anesthetics selectively modulate glutamatergic and dopaminergic signaling via site-specific phosphorylation in vivo

Neuropharmacology, 2007-10, Vol.53 (5), p.619-630

2007

Volltextzugriff (PDF)

Acute Enhancement of Cardiac Function by Phosphodiesterase Type 1 Inhibition

Circulation (New York, N.Y.), 2018-10, Vol.138 (18), p.1974-1987

2018

Volltextzugriff (PDF)

Nerve agent exposure elicits site-specific changes in protein phosphorylation in mouse brain

Brain research, 2010-06, Vol.1342, p.11-23

2010

Volltextzugriff (PDF)

Nicotine regulates DARPP-32 (dopamine- and cAMP-regulated phosphoprotein of 32 kDa) phosphorylation at multiple sites in neostriatal neurons

The Journal of pharmacology and experimental therapeutics, 2005-11, Vol.315 (2), p.872-878

2005

Volltextzugriff (PDF)

Mass Spectrometry of Ribosomes and Ribosomal Subunits

Proceedings of the National Academy of Sciences - PNAS, 1998-06, Vol.95 (13), p.7391-7395

1998

Volltextzugriff (PDF)

ITI-007: A NOVEL THERAPY FOR THE TREATMENT OF SCHIZOPHRENIA AND RELATED PSYCHOSES

Schizophrenia research, 2010-04, Vol.117 (2), p.504-504

2010

Volltextzugriff (PDF)

The presynaptic D2 partial agonist lumateperone acts as a postsynaptic D2 antagonist

Matters, 2018-03

2018

Volltextzugriff (PDF)

Discovery of (S) -2 -( (S) -2 -(3,5 -difluorophenyl ) -2-hydroxyacetamido ) -N-( (S,Z) -3 -methyl -4 -oxo -4,5 -dihydro -3H-benzo[d|[1,2 ]diazepin -5 -yl )propanamide (BMS -433796 ) : A γ-secretase inhibitor with Aβ lowering activity in a transgenic mouse model of Alzheimer's disease

Bioorganic & medicinal chemistry letters, 2007-07, Vol.17 (14), p.4006-4011

2007

Volltextzugriff (PDF)

Control of Folding and Membrane Translocation by Binding of the Chaperone DnaJ to Nascent Polypeptides

Proceedings of the National Academy of Sciences - PNAS, 1993-11, Vol.90 (21), p.10216-10220

1993

Volltextzugriff (PDF)

Regulation of phosphorylation of the GluR1 AMPA receptor by dopamine D2 receptors

Journal of Neurochemistry, 2006-01, Vol.96 (2), p.482-488

2006

Volltextzugriff (PDF)

Regulation of phosphorylation of the GluR1 AMPA receptor by dopamine D 2 receptors

Journal of neurochemistry, 2006-01, Vol.96 (2), p.482-488

2006

Volltextzugriff (PDF)

S81. Unique Pharmacology and Clinical Evidence Supporting the Antidepressant Therapeutic Potential of Lumateperone

Biological psychiatry (1969), 2018-05, Vol.83 (9), p.S378-S378

2018

Volltextzugriff (PDF)

ITI-214, A Novel Phosphodiesterase I Inhibitor for the Treatment of Parkinson’s Disease: Results from A Phase I/II Clinical Study (P2.8-051)

Neurology, 2019-04, Vol.92 (15_supplement)

2019

Volltextzugriff (PDF)

SUPPRESSION OF CNS INFLAMMATION BY PHOSPHODIESTERASE-1 (PDE1) INHIBITORS: TOWARD NEW TREATMENTS FOR NEURODEGENERATIVE DISEASES

Alzheimer's & dementia, 2017-07, Vol.13 (7), p.P1579-P1579

2017

Volltextzugriff (PDF)

Molecular Chaperone Functions of Heat-Shock Proteins

Annual review of biochemistry, 1993-01, Vol.62 (1), p.349-384

1993

Volltextzugriff (PDF)

1 – 25 von 179

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(156)
Mit Volltextzugriff
(152)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(178)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(97)
Life Sciences & Biomedicine
(89)
Humans
(67)
Animals
(44)
Biological And Medical Sciences
(39)
Male
(38)
Female
(31)
Surgery
(25)
Cardiovascular System & Cardiology
(24)
Medical Sciences
(24)
Cardiac & Cardiovascular Systems
(23)
Respiratory System
(16)
Fundamental And Applied Biological Sciences. Psychology
(15)
Mice
(15)
Pharmacology & Pharmacy
(12)
Biochemistry & Molecular Biology
(11)
Middle Aged
(11)
Adult
(10)
Pediatrics
(10)
Mice, Inbred C57bl
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Gamma-secretase activating protein is a therapeutic target for Alzheimer's disease

Acute Enhancement of Cardiac Function by Phosphodiesterase Type 1 Inhibition: Translational Study in the Dog and Rabbit

Functional profile of a novel modulator of serotonin, dopamine, and glutamate neurotransmission

Discovery of a Tetracyclic Quinoxaline Derivative as a Potent and Orally Active Multifunctional Drug Candidate for the Treatment of Neuropsychiatric and Neurological Disorders

Discovery of Potent and Selective Inhibitors of Phosphodiesterase 1 for the Treatment of Cognitive Impairment Associated with Neurodegenerative and Neuropsychiatric Diseases

Inhibition of calcium-calmodulin-dependent phosphodiesterase (PDE1) suppresses inflammatory responses

Preclinical profile of ITI-214, an inhibitor of phosphodiesterase 1, for enhancement of memory performance in rats

Phosphodiesterase 1: A Unique Drug Target for Degenerative Diseases and Cognitive Dysfunction

Muscarinic receptors acting at pre- and post-synaptic sites differentially regulate dopamine/DARPP-32 signaling in striatonigral and striatopallidal neurons

In vivo observation of polypeptide flux through the bacterial chaperonin system

General anesthetics selectively modulate glutamatergic and dopaminergic signaling via site-specific phosphorylation in vivo

Acute Enhancement of Cardiac Function by Phosphodiesterase Type 1 Inhibition

Nerve agent exposure elicits site-specific changes in protein phosphorylation in mouse brain

Nicotine regulates DARPP-32 (dopamine- and cAMP-regulated phosphoprotein of 32 kDa) phosphorylation at multiple sites in neostriatal neurons

Mass Spectrometry of Ribosomes and Ribosomal Subunits

ITI-007: A NOVEL THERAPY FOR THE TREATMENT OF SCHIZOPHRENIA AND RELATED PSYCHOSES

The presynaptic D2 partial agonist lumateperone acts as a postsynaptic D2 antagonist

Discovery of (S) -2 -( (S) -2 -(3,5 -difluorophenyl ) -2-hydroxyacetamido ) -N-( (S,Z) -3 -methyl -4 -oxo -4,5 -dihydro -3H-benzo[d|[1,2 ]diazepin -5 -yl )propanamide (BMS -433796 ) : A γ-secretase inhibitor with Aβ lowering activity in a transgenic mouse model of Alzheimer's disease

Control of Folding and Membrane Translocation by Binding of the Chaperone DnaJ to Nascent Polypeptides

Regulation of phosphorylation of the GluR1 AMPA receptor by dopamine D2 receptors

Regulation of phosphorylation of the GluR1 AMPA receptor by dopamine D 2 receptors

S81. Unique Pharmacology and Clinical Evidence Supporting the Antidepressant Therapeutic Potential of Lumateperone

ITI-214, A Novel Phosphodiesterase I Inhibitor for the Treatment of Parkinson’s Disease: Results from A Phase I/II Clinical Study (P2.8-051)

SUPPRESSION OF CNS INFLAMMATION BY PHOSPHODIESTERASE-1 (PDE1) INHIBITORS: TOWARD NEW TREATMENTS FOR NEURODEGENERATIVE DISEASES

Molecular Chaperone Functions of Heat-Shock Proteins

Suchergebnisse filtern